Protalix Biotherapeutics Inc (PLX)
R&D Expenses
$19.88M
TTM · Period ending: · USD
PLX R&D Expenses
Latest reported$19.88Mperiod ending
Latest reported$19.88Mperiod ending
PLX TTM R&D Expenses ($0.00 → $19.88M)
TTM R&D Expenses
High-resolution chart · PNG
PLX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |